H. Pylori Treatment: Triple Therapy, Quadruple Therapy & What Actually Works

H. pylori treatment typically involves a combination of antibiotics and an acid-reducing drug taken for 10–14 days. Standard triple therapy pairs a proton pump inhibitor with two antibiotics (usually amoxicillin and clarithromycin), but rising antibiotic resistance means many doctors now prescribe bismuth quadruple therapy instead. Success is confirmed with a follow-up test 4+ weeks after treatment ends.

Helicobacter pylori (H. pylori) is a common bacterial infection that can colonize the stomach. A 2017 systematic review and meta-analysis found that 257,768 of 531,880 participants tested positive across studies from 62 countries, corresponding to a pooled prevalence of 48.5%.

IARC’s 2025 report cites this analysis and summarizes the global prevalence as approximately 48%, while noting substantial geographical variation.

Many people with H. pylori have no obvious symptoms. However, persistent infection can cause chronic gastritis and is strongly associated with peptic ulcer disease. H. pylori is also classified by the International Agency for Research on Cancer (IARC) as a Group 1 carcinogen because of its established association with gastric cancer.

For people who are diagnosed with H. pylori infection, current clinical guidance recommends treatment aimed at eradicating the bacterium, rather than simply controlling stomach acid production. Successful eradication can reduce the risk of recurrent H. pylori-associated ulcers and forms an important part of gastric cancer prevention strategies.

Current recommendations have moved toward treating patients found to have an active H. pylori infection, rather than assuming that treatment is only necessary when symptoms are present. The 2024 American College of Gastroenterology (ACG) guideline recommends treatment for adults with confirmed H. pylori infection and emphasizes confirming eradication after therapy. The guideline also recommends choosing treatment based on previous antibiotic exposure and susceptibility considerations.

This is important because absence of symptoms does not necessarily mean absence of risk. H. pylori can persist in the stomach for years and contribute to chronic inflammation and progressive changes in the gastric lining.

At the same time, symptoms alone cannot confirm H. pylori. Similar symptoms can occur with acid reflux, functional dyspepsia, gastritis, gallbladder disease and other gastrointestinal conditions. Testing is therefore important before starting antibiotic treatment.

H. pylori infection does not always cause noticeable symptoms. When symptoms occur, they may be related to gastritis or an ulcer rather than the bacterium itself.

However, these symptoms are not specific to H. pylori. Testing is needed to determine whether the infection is actually present.

Seek prompt medical evaluation if digestive symptoms are accompanied by warning signs such as:

• Black, tarry stools

• Vomiting blood or material resembling coffee grounds

• Persistent or severe abdominal pain

• Repeated vomiting

• Unexplained or significant weight loss

• Difficulty or pain when swallowing

• Anemia or persistent fatigue associated with suspected gastrointestinal blood loss

These symptoms can indicate an ulcer, gastrointestinal bleeding or another significant gastrointestinal condition and should not be self-treated with H. pylori antibiotics.

Testing is important because H. pylori treatment should generally be based on evidence of active infection. Different tests detect the infection in different ways. Urea breath tests and stool antigen tests are commonly used to detect active infection and confirm whether treatment has worked.

If you have symptoms or have been advised to confirm H. pylori infection, you can explore H. pylori testing with MyDiagnostics. The available options include a stool antigen test  and a urea breath test. Choose the test recommended by your healthcare professional, particularly if you are checking whether treatment has been successful.

H. pylori triple therapy is a traditional treatment used to eliminate Helicobacter pylori from the stomach.

• What it contains: One proton pump inhibitor (PPI) + two antibiotics, traditionally amoxicillin + clarithromycin.

• Typical duration: Usually 10–14 days, depending on the prescribed regimen.

• How it works: The PPI reduces stomach acid, while the two antibiotics target and kill H. pylori.

• Why it was widely used: Triple therapy became a historical first-line treatment because combining acid suppression with two antibiotics improved eradication compared with single-drug treatment.

The traditional combination includes:

• PPI: Reduces stomach acid and supports healing of the stomach lining.

• Amoxicillin: Antibiotic that attacks H. pylori.

• Clarithromycin: Antibiotic that targets H. pylori through a different mechanism.

Dosing pattern: These medicines are generally taken at specific times throughout the day for the prescribed 10–14-day course. The exact dose and schedule vary according to the treatment protocol and individual patient factors.

Important: Antibiotics for helicobacter pylori treatment should only be taken according to a healthcare professional's prescription. Previous antibiotic use and local resistance patterns can influence which regimen is appropriate.

The answer depends on whether you mean symptom relief or bacterial eradication:

• Symptom relief: Stomach pain, nausea, bloating or indigestion may start improving during treatment or shortly afterward.

• H. pylori eradication: Feeling better does not confirm that the bacteria have been eliminated.

• Complete the course: Do not stop treatment early simply because symptoms improve. Completing the prescribed regimen helps maximize the chance of successful eradication.

• Confirmation testing: A stool antigen test or urea breath test is generally performed at least 4 weeks after completing antibiotics to confirm whether treatment worked.

• Before testing: Your healthcare professional may ask you to stop PPIs for about 2 weeks before the test because they can affect test accuracy.

The effectiveness of traditional triple therapy has changed over time.

• Historically: clarithromycin-based triple therapy was widely used as a first-line H. pylori treatment. Its effectiveness depends on factors such as clarithromycin susceptibility, treatment adherence and the specific regimen used.

• Today: Success is less predictable because H. pylori antibiotic resistance, particularly clarithromycin resistance, has increased.

• Resistance matters: When helicobacter pylori infection is resistant to clarithromycin, clarithromycin-containing triple therapy can have a substantially lower eradication rate.

• Other reasons for treatment failure: Missed doses, incomplete treatment, previous antibiotic exposure and previous unsuccessful H. pylori therapy can also reduce treatment success.

• Current approach: When clarithromycin susceptibility is unknown, current guidelines generally favor non-clarithromycin-based options rather than routinely using traditional clarithromycin triple therapy.

Bottom line: Triple therapy remains an important part of H. pylori treatment history, but the most effective H. pylori regimen depends on antibiotic resistance, previous treatment and individual patient factors. This is why treatment selection should be guided by a healthcare professional rather than using the same antibiotic combination for everyone.

H. pylori triple therapy is failing more often primarily because of increasing antibiotic resistance, especially resistance to clarithromycin. This has changed how doctors select H. pylori treatment, with current guidelines moving away from routine clarithromycin-based triple therapy when antibiotic susceptibility is unknown.

Other factors can also contribute to treatment failure:

• Antibiotic resistance: H. pylori may become resistant to one or more antibiotics used in treatment.

• Incomplete treatment: Stopping antibiotics before completing the prescribed course can reduce the chance of successful eradication.

• Missed doses: Not taking medicines as directed can make treatment less effective.

• Previous antibiotic exposure: Earlier use of antibiotics such as clarithromycin can influence treatment choices.

• Previous treatment failure: If one regimen has already failed, repeating the same combination may be less effective.

• Drug interactions or inadequate acid suppression: These can sometimes affect treatment effectiveness.

• Reinfection: Reinfection can occur, but a positive test soon after treatment should first prompt a review of the test timing, treatment adherence and the possibility of persistent infection or treatment failure.

The 2024 American College of Gastroenterology (ACG) guideline recommends avoiding clarithromycin-containing triple therapy when susceptibility to clarithromycin has not been demonstrated. Instead, clinicians may select alternative regimens based on treatment history, antibiotic susceptibility and other patient-specific factors.

Clarithromycin resistance means that H. pylori can survive despite treatment with clarithromycin, making clarithromycin-based therapy less likely to eradicate the infection.

In simple terms, the antibiotic may have worked against H. pylori in the past, but resistant bacteria can withstand its effects.

• Why it matters: Clarithromycin resistance is one of the major reasons traditional triple therapy can fail.

• Resistance varies by region: H. pylori antibiotic resistance is not the same everywhere. Doctors may consider local resistance patterns when selecting an eradication regimen.

• Previous antibiotic use matters: A history of taking macrolide antibiotics, including clarithromycin, can increase the likelihood that a clarithromycin-containing regimen will be unsuitable.

• One-size-fits-all treatment is changing: Because resistance patterns differ between populations, traditional clarithromycin triple therapy is no longer routinely recommended as an empiric first-line option when susceptibility is unknown.

• Alternative treatments: Depending on the patient's circumstances, doctors may choose bismuth quadruple therapy or another recommended non-clarithromycin regimen.

This shift is an important reason why the best H. pylori treatment cannot be determined by the number of medicines alone. The most appropriate regimen depends on factors such as antibiotic resistance, previous treatment and medication history.

Symptoms alone cannot confirm whether H. pylori treatment has failed. Some people continue to experience digestive symptoms even after successful eradication, while others may have persistent infection without significant symptoms.

Possible indicators include:

• Persistent symptoms: Stomach pain, nausea, bloating, indigestion or frequent burping continue after treatment.

• Returning symptoms: Symptoms improve temporarily but return after completing the treatment.

• Positive confirmation test: A properly timed stool antigen or urea breath test remains positive after treatment.

• Persistent infection despite completing treatment: This may indicate antibiotic resistance, inadequate adherence or another treatment-related factor.

Important: Do not restart or repeat H. pylori antibiotics without medical advice. A positive follow-up test should prompt a review of the previous regimen and selection of an appropriate alternative treatment.

H. pylori eradication rates vary substantially by regimen, antibiotic susceptibility, treatment history and adherence. A single success rate should not be used to represent every patient or every treatment setting.

The 2024 ACG guideline favors optimized bismuth quadruple therapy for 14 days when antibiotic susceptibility is unknown. Rifabutin-based triple therapy and vonoprazan-amoxicillin dual therapy are suggested alternatives in appropriate patients. Clarithromycin- and levofloxacin-containing regimens should generally be reserved for situations where susceptibility has been demonstrated.

For this reason, it is more accurate to compare regimens by their components, duration and clinical use than to quote isolated eradication percentages without the supporting study.

When traditional H. pylori triple therapy may not be suitable because of antibiotic resistance, doctors may choose quadruple therapy or newer combination regimens. The choice depends on previous antibiotic exposure, allergies, treatment history and local resistance patterns.

Bismuth quadruple therapy combines four medicines and is a commonly recommended first-line option when antibiotic susceptibility is unknown.

• Components: Bismuth + a PPI + tetracycline and metronidazole.

• Typical duration: Usually 14 days.

• Why it is used: It does not rely on clarithromycin, making it an important option when clarithromycin resistance is a concern.

• How it differs from triple therapy: Triple therapy traditionally uses one PPI + two antibiotics, while quadruple therapy adds bismuth as a fourth component.

• Important: The exact medicines and dosing schedule should be determined by a doctor.

Several newer H. pylori treatment options are also available and may be considered depending on the patient's circumstances.

• Vonoprazan-based regimens: Use a potassium-competitive acid blocker (PCAB) for stronger and more sustained acid suppression, combined with appropriate antibiotics.

• Rifabutin-based therapy: Uses rifabutin with acid suppression and amoxicillin and may be considered in certain treatment settings, including some cases where previous therapy has failed.

• Why these options matter: They provide alternatives when traditional clarithromycin-based treatment is unsuitable or unsuccessful.

• Treatment is individualized: The most effective H. pylori regimen depends on factors such as previous antibiotic use, resistance patterns, allergies and whether earlier treatment has failed.

Which H. pylori treatment has the highest success rate? There is no single regimen that is best for every patient. The most appropriate treatment depends on antibiotic susceptibility, previous antibiotic exposure, treatment history, allergies and adherence. A regimen that works well in one study or population may not have the same success rate in another.

Voquezna Triple Pak and Voquezna Dual Pak are branded vonoprazan-based H. pylori treatment regimens. The key difference is that Triple Pak includes clarithromycin, while Dual Pak does not. Voquezna Triple Pak is taken twice daily, while Voquezna Dual Pak is taken three times daily.

The choice between these regimens depends on antibiotic susceptibility, previous treatment, allergies and other clinical factors. The 2024 ACG guideline recommends PCAB dual therapy as a suggested first-line option and PCAB triple therapy when appropriate, while emphasizing that clarithromycin-containing regimens should not be used empirically without demonstrated susceptibility.

Side effects of H. pylori triple therapy treatment are relatively common because the regimen combines multiple medicines, including antibiotics and an acid-suppressing drug. Most side effects are temporary and manageable, but some symptoms require medical attention.

Side effects can vary depending on the specific H. pylori antibiotics and treatment regimen used.

Some commonly reported side effects during H. pylori treatment include:

• Nausea or stomach discomfort: Can occur because of the antibiotics.

• Metallic or bitter taste: Particularly associated with some antibiotics such as metronidazole.

• Diarrhea or loose stools: Antibiotics can temporarily alter the normal gut microbiome.

• Bloating or indigestion: Digestive changes may occur during treatment.

• Dark stools or tongue: Bismuth-containing regimens can temporarily cause darkening of the stool or tongue; this is usually harmless.

• Yeast infection: Antibiotics can sometimes disrupt the normal balance of microorganisms, increasing the risk of vaginal or oral yeast infections.

• Headache: May occur with some medicines used in H. pylori treatment.

Usually manageable: Mild nausea, temporary taste changes and mild loose stools can occur during treatment and often improve after the course is completed.

Contact your doctor: Persistent vomiting, severe abdominal discomfort, troublesome diarrhea, significant dehydration or side effects that make it difficult to take your medicines should be discussed with a healthcare professional.

Seek urgent medical attention: Difficulty breathing, swelling of the face, lips or throat, widespread hives, fainting or other signs of a severe allergic reaction require immediate medical care. Severe or persistent diarrhea, particularly if accompanied by fever, blood or significant abdominal pain, also warrants prompt medical evaluation.

A few practical measures may make H. pylori treatment easier to tolerate:

• Follow medicine instructions: Some medicines should be taken with food while others may need to be taken before meals. Follow the instructions provided with your prescription rather than taking every medicine with food automatically.

• Stay hydrated: Drink adequate fluids, particularly if you experience diarrhea or nausea.

• Eat smaller meals: Light, smaller meals may be easier to tolerate if antibiotics cause nausea.

• Consider probiotics: Some evidence suggests probiotics may help reduce certain antibiotic-associated gastrointestinal side effects. However, probiotics do not replace H. pylori antibiotics or eradication therapy.

• Avoid alcohol when advised: Some antibiotics, particularly metronidazole, can interact with alcohol. Follow your doctor's or pharmacist's instructions.

• Complete the prescribed course: Do not stop treatment simply because side effects occur or symptoms improve. If side effects become difficult to manage, contact your healthcare professional for advice.

An H. pylori diet may help reduce stomach irritation and make symptoms more manageable during treatment, but diet cannot replace antibiotics or prescribed eradication therapy. There is no specific food proven to eliminate H. pylori on its own.

If your stomach is inflamed, certain foods and drinks may increase discomfort, acidity or indigestion:

• Spicy foods: May aggravate burning or stomach discomfort in some people.

• Acidic foods: Citrus fruits, tomatoes and other acidic foods may worsen symptoms for some individuals.

• Fried and high-fat foods: Can increase indigestion, bloating or nausea.

• Highly processed foods: May be harder to tolerate when the stomach is irritated.

• Alcohol: Can irritate the stomach lining and may interact with some H. pylori medicines.

• Caffeine: Coffee and other caffeinated drinks may worsen acidity or stomach discomfort in some people.

• Carbonated drinks: May increase bloating, belching or abdominal discomfort.

Tip: Food triggers vary from person to person. Rather than following an unnecessarily restrictive diet, identify and limit foods that consistently worsen your symptoms.

Some foods have been studied for their potential effects on H. pylori or digestive health, but they should be viewed as supportive—not curative.

• Broccoli sprouts: Contain sulforaphane, a compound that has shown anti-H. pylori activity in research, but they should not be considered a replacement for eradication treatment.

• Honey, including Manuka honey: Has demonstrated antibacterial activity in laboratory research, but there is insufficient evidence that eating honey alone can eradicate H. pylori in people.

• Green tea: Contains polyphenols with potential antimicrobial and antioxidant properties, but it is not an established H. pylori treatment.

• Probiotic-rich foods: Yogurt and other fermented foods may support gut health and may help with some antibiotic-related digestive symptoms. They do not eliminate H. pylori by themselves.

• Smaller, frequent meals: Eating smaller portions throughout the day may be easier to tolerate than large meals when experiencing nausea, bloating or stomach discomfort.

• Stay hydrated: Adequate fluid intake can help prevent dehydration, particularly if treatment causes diarrhea or vomiting.

• Manage stress: Stress does not cause H. pylori infection, but stress can worsen digestive symptoms and make stomach discomfort more noticeable. Relaxation techniques, adequate sleep and regular physical activity may help with overall symptom management.

No. H. pylori infection should not be expected to clear on its own, and natural remedies or diet alone have not been proven to reliably eradicate the bacteria. For confirmed H. pylori infection, medical eradication therapy remains the standard approach.

Leaving the infection untreated can allow chronic inflammation of the stomach lining to continue and may increase the risk of peptic ulcers and gastric cancer over time.

Some dietary measures and supplements may provide supportive benefits, but they should not be considered a cure for H. pylori.

• Diet: Avoiding foods that trigger acidity, burning or indigestion may help manage symptoms during treatment.

• Probiotics: May support gut health and potentially reduce some antibiotic-related digestive side effects, but they cannot reliably eliminate H. pylori on their own.

• Honey, green tea and broccoli sprouts: These contain compounds that have shown potential anti-H. pylori effects in laboratory or limited human research, but evidence is not strong enough to recommend them as standalone eradication treatments.

• Healthy eating and hydration: Can support overall digestive health and make treatment easier to tolerate.

• Stress management: May help reduce digestive discomfort, although it does not eliminate the underlying infection.

Why antibiotics matter: H. pylori is a bacterial infection that can persist in the stomach for years. If antibiotics are skipped, the underlying infection may remain even if symptoms temporarily improve.

For this reason, people with confirmed H. pylori should not replace prescribed eradication therapy with supplements or home remedies. If standard treatment causes troublesome side effects or is not suitable, speak with a doctor about alternative treatment options.

The only reliable way to know whether H. pylori treatment worked is to complete a properly timed test of cure. Feeling better does not necessarily mean that the bacteria have been eradicated.

• Symptoms can improve before eradication: Reduced stomach pain, nausea or bloating does not confirm that H. pylori is gone.

• Symptoms may persist for other reasons: Ongoing digestive symptoms do not always mean treatment has failed.

• Confirmation testing is essential: A follow-up test checks whether H. pylori has actually been eliminated.

• Do not retest too early: Testing soon after treatment can produce a false-negative result.

Current guidelines recommend confirming H. pylori eradication in all treated patients.

• When to test: Retesting should generally be performed at least 4 weeks after completing antibiotics.

• Before the test: PPIs and other acid-suppressing medicines may need to be stopped for about 2 weeks, under medical guidance, because they can suppress H. pylori and cause a false-negative result.

• Preferred tests: A urea breath test or stool antigen test can be used to confirm eradication.

• Endoscopy-based testing: If an endoscopy is clinically indicated, biopsy-based testing may also be used.

• Blood antibody tests: Generally not suitable for confirming eradication because H. pylori antibodies can remain detectable after the infection has been cleared.

Why wait? The waiting period gives the treatment enough time to work and reduces the chance of temporarily suppressed bacteria producing a misleading negative result.

Planning to confirm whether H. pylori treatment has worked? MyDiagnostics offers H. pylori testing options, including stool antigen testing. Explore the H. pylori stool antigen test  and discuss the appropriate timing and preparation with your healthcare professional.

A positive follow-up test means the infection has not been successfully eradicated and requires further medical management.

• Don't repeat the same treatment on your own: The next regimen is usually selected based on the treatment already received.

• Rescue therapy: A doctor may prescribe a different combination of antibiotics and acid suppression, often using a regimen that avoids antibiotics to which resistance is suspected.

• Review previous antibiotics: Your doctor may consider which antibiotics you have taken previously when choosing the next regimen.

• Susceptibility testing: After treatment failure, antibiotic susceptibility testing may help identify which medicines are likely to work, particularly after repeated eradication failures.

• Confirm again: A further test of cure is performed after completing the next treatment course.

Reassurance: Treatment failure does not mean H. pylori cannot be cured. Most persistent infections can be successfully eradicated by selecting an appropriate alternative regimen based on previous treatment and resistance considerations.

Medical Disclaimer: This article is for general informational and educational purposes only and does not replace professional medical advice, diagnosis, or treatment. H. pylori treatment should be prescribed and monitored by a qualified healthcare professional. Do not start, stop, or change antibiotics or other medicines without medical guidance. If you have persistent or severe symptoms, seek medical attention promptly.